An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions

Completed

• Conditions: Lung Cancer

• Registration Number: NCT03535766
• Lead Sponsor: St Elizabeth Healthcare

Brief Summary

This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-03-01
• Study First Submitted: 2018-05-07
• Study First Submitted QC: 2018-05-22
• Study First Posted: 2018-05-24
• Primary Completion: 2021-07-01
• Study Completion: 2023-01-09
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-11
• Last Update Posted: 2024-07-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2100

Inclusion Criteria

• Patient seen within the St. Elizabeth system
• >=18 years of age
• New diagnosis of histologically or cytologically documented primary lung cancer diagnosed January 2013 or later

Exclusion Criteria

• Patients with metastatic lung disease of other primary
• Other malignancies at investigator's discretion
• Patient received treatment at a facility outside of St. Elizabeth where records are not available through EPIC
• Patient currently undergoing treatment for new diagnosis of lung cancer

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time from presentation to treatment	from initial patient presentation with symptoms or incidental finding to first day of treatment, up to 3 years	Time from initial patient presentation with symptoms or incidental finding to first day of treatment, measured in days.

Secondary Outcome Measures

Name	Time	Method
Additional time between imaging and physician referrals	From identification of concerning nodule to specialist appointment, up to 3 years

Trial Locations

Locations (1)

St. Elizabeth Healthcare; 🇺🇸 Edgewood, Kentucky, United States